Their tight regulation is, in part, mediated by an extracellular matrix metalloproteinase inducer (EMMPRIN), a glycoprotein commonly enriched on the surface of tumour cells and associated with tumour progression and poor patient outcomes [34,35]. Here, BSG is linked to neoplasm.